MYP_174365
Basic Information
Chgkaalac
Antimicrobial Antifungal
Antimicrobial Antifungal Beauverolide
Standard
7 amino acids
C29H36N10O1S2
Standard
Sequence
CHGKLAC
Physicochemical Analysis
730.90 Da
8.16
0.96
0.75
0.1378
0.44
0.24
0.12
78.84
70.00
0.1429
0.00
125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
248.67
0.39
7.0
12.0
13.0
44.0
1.0
11.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0427678 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Structure & Mods
cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
Terminal cysteine disulfide cyclization in the transformed nonapeptide
CyclicPepedia normalized one-letter core CHGKLAC maps to experimental transformed sequence CHGKAALAC
Bio-Activity Profile
Antiviral Andes virus infection inhibition Surface glycoprotein binding
Andes virus strain CHI-7913; surface glycoproteins Gn/Gc; Vero E6 cells
27.22 %
ANDV infection inhibition by peptide-bearing phage; immunofluorescence assay (IFA)